11-1841527-G-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_003282.4(TNNI2):c.525G>T(p.Lys175Asn) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 33)
Consequence
TNNI2
NM_003282.4 missense
NM_003282.4 missense
Scores
8
10
1
Clinical Significance
Conservation
PhyloP100: 5.11
Genes affected
TNNI2 (HGNC:11946): (troponin I2, fast skeletal type) This gene encodes a fast-twitch skeletal muscle protein, a member of the troponin I gene family, and a component of the troponin complex including troponin T, troponin C and troponin I subunits. The troponin complex, along with tropomyosin, is responsible for the calcium-dependent regulation of striated muscle contraction. Mouse studies show that this component is also present in vascular smooth muscle and may play a role in regulation of smooth muscle function. In addition to muscle tissues, this protein is found in corneal epithelium, cartilage where it is an inhibitor of angiogenesis to inhibit tumor growth and metastasis, and mammary gland where it functions as a co-activator of estrogen receptor-related receptor alpha. This protein also suppresses tumor growth in human ovarian carcinoma. Mutations in this gene cause myopathy and distal arthrogryposis type 2B. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM1
In a chain Troponin I, fast skeletal muscle (size 180) in uniprot entity TNNI2_HUMAN there are 8 pathogenic changes around while only 0 benign (100%) in NM_003282.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.918
PP5
Variant 11-1841527-G-T is Pathogenic according to our data. Variant chr11-1841527-G-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 212411.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-1841527-G-T is described in Lovd as [Likely_pathogenic]. Variant chr11-1841527-G-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNNI2 | NM_003282.4 | c.525G>T | p.Lys175Asn | missense_variant | 8/8 | ENST00000381911.6 | NP_003273.1 | |
TNNI2 | NM_001145829.2 | c.525G>T | p.Lys175Asn | missense_variant | 8/8 | NP_001139301.1 | ||
TNNI2 | NM_001145841.2 | c.525G>T | p.Lys175Asn | missense_variant | 6/6 | NP_001139313.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNNI2 | ENST00000381911.6 | c.525G>T | p.Lys175Asn | missense_variant | 8/8 | 2 | NM_003282.4 | ENSP00000371336.1 | ||
TNNI2 | ENST00000252898.11 | c.525G>T | p.Lys175Asn | missense_variant | 7/7 | 3 | ENSP00000252898.7 | |||
TNNI2 | ENST00000381905.3 | c.525G>T | p.Lys175Asn | missense_variant | 6/6 | 3 | ENSP00000371330.3 | |||
TNNI2 | ENST00000381906.5 | c.525G>T | p.Lys175Asn | missense_variant | 8/8 | 3 | ENSP00000371331.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Distal arthrogryposis type 2B1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | May 06, 2021 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0101 - Gain of function is a known mechanism of disease in this gene and is associated with distal arthrogryposis type 2B1 (DA2B; MIM#601680) (PMIDs: 17194691, 25340332). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity (PMID: 27790376). (I) 0200 - Variant is predicted to result in a missense amino acid change from lysine to asparagine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants (DECIPHER). (SP) 0705 - No comparable missense variants have previous evidence for pathogenicity. However, an inframe-deletion of the same residue, p.(Lys175del) also known as p.(Lys176del), has been reported in individuals with DA2B (PMID: 26526134), demonstrating the importance of this amino acid for protein function. (I) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. It has been reported in 3 unrelated individuals with DA2B (PMID: 23401156, ClinVar, LOVD). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1102 - Strong phenotype match for this individual. (SP) 1204 - This variant has been shown to be de novo in the proband (parental status not tested but assumed). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 22, 2014 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D;.;D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;.;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;M;.;M;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;.;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;.;D;D
Sift4G
Uncertain
D;D;D;D;D
Polyphen
D;D;.;D;.
Vest4
MutPred
Loss of ubiquitination at K175 (P = 0.0067);Loss of ubiquitination at K175 (P = 0.0067);Loss of ubiquitination at K175 (P = 0.0067);Loss of ubiquitination at K175 (P = 0.0067);Loss of ubiquitination at K175 (P = 0.0067);
MVP
MPC
0.95
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at